Stellar Biotechnologies competitorsClear all

Stellar Biotechnologies's top competitors include Ironwood Pharmaceuticals and MyoKardia.
Stellar Biotechnologies
Stellar Biotechnologies
Stellar Biotechnologies is a biotechnology company.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Founding Date
Founding Date
1999
Founding Date
N/A
Founding Date
2012
Type
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Port Hueneme, US HQ
Locations
Cambridge, US HQ
Boston, US
Locations
South San Francisco, US HQ
Brisbane, US
Employees
Employees
118% decrease
Employees
31738% decrease
Employees
23542% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1.9 b
Valuation ($)
12 b
Twitter followers
Twitter followers
226
Twitter followers
3.7 k
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.3
Average likes per tweet (last 30 days)
14.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
62.5%
Percentage of tweets with engagement (last 30 days)
100%
Employee Rating
Employee Rating
N/A
Employee Rating
4
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
$410.9k (FY, 2019)
Revenue (est.)
$428.4m (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$101.3k (FY, 2019)
Cost of goods
$23.9m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
$309.6k (FY, 2019)
Gross profit
$404.5m (FY, 2019)
Gross profit
N/A
Net income
Net income
($2.8m) (FY, 2019)
Net income
$21.5m (FY, 2019)
Net income
($276.2m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 24.3m
Total funding raised
$ 609m
Total funding raised
$ 98m
For sources of this data, please see the company profile

View company profiles

Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
317↓ 38% decrease

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company